> Detailanzeige

Jafari, Behzad; Jalil, Saquib; Zaib, Sumera; Safarov, Sayfidin; Khalikova, Muattar; Khalikov, Djurabay; Ospanov, Meirambek; Yelibayeva, Nazym; Zhumagalieva, Shynar; Abilov, Zharylkasyn A.; Turmukhanova, Mirgul Z.; Kalugin, Sergey N.; Salman, Ghazwan Ali; Ehlers, Peter; Hameed, Abdul; Iqbal, Jamshed; Langer, Peter

Synthesis of 2‐Alkynyl‐ and2‐Amino‐12H‐benzothiazolo[2,3‐b]quinazolin‐12‐ones and Their Inhibitory Potential against Monoamine Oxidase A and B

Literatur-
verwaltung

Zur
Merkliste

Lösche von
Merkliste

Per Whatsapp teilen

Schließen

Merkliste



Sie können Bookmarks mittels Listen verwalten, loggen Sie sich dafür bitte in Ihr SLUB Benutzerkonto ein.
  • Medientyp: E-Artikel
  • Titel: Synthesis of 2‐Alkynyl‐ and2‐Amino‐12H‐benzothiazolo[2,3‐b]quinazolin‐12‐ones and Their Inhibitory Potential against Monoamine Oxidase A and B
  • Beteiligte: Jafari, Behzad; Jalil, Saquib; Zaib, Sumera; Safarov, Sayfidin; Khalikova, Muattar; Khalikov, Djurabay; Ospanov, Meirambek; Yelibayeva, Nazym; Zhumagalieva, Shynar; Abilov, Zharylkasyn A.; Turmukhanova, Mirgul Z.; Kalugin, Sergey N.; Salman, Ghazwan Ali; Ehlers, Peter; Hameed, Abdul; Iqbal, Jamshed; Langer, Peter
  • Erschienen: Wiley, 2019
  • Erschienen in: ChemistrySelect, 4 (2019) 47, Seite 13760-13767
  • Sprache: Englisch
  • DOI: 10.1002/slct.201903300
  • ISSN: 2365-6549
  • Schlagwörter: General Chemistry
  • Entstehung:
  • Anmerkungen:
  • Beschreibung: Abstract2‐Alkynyl‐ and 2‐aminobenzothiazolo[2,3‐b]quinazolin‐12‐ones have been synthesized by Palladium catalysed Buchwald‐Hartwig and Sonogashira reactions. Synthesized derivatives were further evaluated for their role as potential inhibitors of monoamine oxidase A and B (MAO−A and B) isozymes. Most compounds possess moderate to excellent inhibitory potential against MAO−A and MAO−B. The 2‐amino‐substituted derivatives show a significantly higher activity as compared to 2‐alkynyl‐ and previously reported 2‐aryl derivatives. Studied compounds might be employed as novel monoamine oxidase inhibitors and may provide insights for the development of new drug candidates against neurological diseases.